The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout
The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout

Chinese Covid-19 vaccine gets UAE nod for therapeutic use trial

  • Approval follows earlier green light in the UAE and New Zealand for preventive use trials of YishengBio vaccine
  • Patients with mild to moderate Covid-19 infections will be targeted first in trial of regimen involving two shots seven days apart

Topic |   Chinese coronavirus vaccines
The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout
The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout
READ FULL ARTICLE